Braingaze

Braingaze is a technology-driven startup based in Spain, founded in 2013, specializing in early-stage detection and therapeutic support tools for cognitive disorders and diseases such as ADHD, ASD, and Alzheimer's Disease. The company's patented solutions leverage AI and analytics to detect, diagnose, and treat these conditions by employing eye movement cognitive vergence as a marker of cognitive processing. With a focus on leveraging brain circuits connected to small involuntary eye movements, Braingaze has attracted significant attention, as evidenced by its recent €1.50M Venture Round investment on 06 March 2024. Notably, this last investment was made by Artesian, Orbit Startups, and RYSE Asset Management, reflecting confidence in Braingaze's innovative approach. With a team consisting of scientists, mathematicians, AI experts, and entrepreneurs, Braingaze is well-positioned to make further strides in the health care industry and contribute to the advancement of diagnostic and therapeutic tools.